F19.282
Other psychoactive substance dependence with psychoactive substance-induced sleep disorder
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code F19.282 refers to a condition where an individual has developed dependence on various psychoactive substances, which is further complicated by a sleep disorder caused or worsened by the substance use. Psychoactive substances include drugs that alter brain function, impacting mood, perception, or consciousness. Dependence indicates a compulsive need to use the substance despite harmful consequences. When dependence is combined with a sleep disorder induced by the substance, it poses additional challenges for treatment and recovery. Recognizing this condition is important for healthcare providers to develop comprehensive treatment plans tailored to address both substance dependence and sleep disturbances.
Causes & Symptoms
Clinical Causes: Prolonged and frequent use of psychoactive substances such as opioids, sedatives, stimulants, or hallucinogens Self-medication for underlying mental health issues like anxiety or depression Genetic predisposition influencing susceptibility to dependence and sleep problems Environmental stressors and social factors that promote substance use Development of tolerance, leading to increased consumption and dependence Substance-induced effects altering sleep-wake cycles
Key Symptoms: Craving or strong desire to use the psychoactive substance Tolerance, requiring higher doses to achieve the same effect Withdrawal symptoms when not using the substance Persistent unsuccessful efforts to cut down or control use Neglect of personal, occupational, or social responsibilities Sleep disturbances such as difficulty falling asleep, staying asleep, or non-restorative sleep Vivid dreams or nightmares related to substance use Daytime fatigue and irritability due to poor sleep Anxiety or agitation linked to sleep issues or substance cravings
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive assessment including detailed patient history, physical examination, and possibly laboratory tests to confirm substance dependence. Healthcare providers may use standardized screening questionnaires for substance use and sleep disorders. Differential diagnosis is important to distinguish between primary sleep disorders and those induced by substances. Monitoring withdrawal signs and assessing the severity of dependence also aid in diagnosis. Collaboration with specialists in addiction medicine and sleep medicine might be necessary for an accurate and holistic evaluation.
Treatment Protocols: Detoxification under medical supervision for managing withdrawal symptoms Counseling and psychotherapy, such as cognitive-behavioral therapy, to address dependence and patterns of substance use Medications to manage cravings or prevent relapse, tailored to the specific substance involved Interventions targeting sleep disturbances, such as sleep hygiene education and, when appropriate, medications for sleep support Support groups and community resources for ongoing recovery and social reintegration Addressing co-occurring mental health issues to improve overall treatment outcomes
Clinical Advice & FAQs
Billing Guidance
Is F19.282 a billable ICD-10 code?
Yes, F19.282 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.282?
Clinical documentation must specify the nature of Other psychoactive substance dependence with psychoactive substance-induced sleep disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference